Please login to the form below

Not currently logged in
Email:
Password:

clinical benefit

This page shows the latest clinical benefit news and features for those working in and with pharma, biotech and healthcare.

Biogen and Eisai claim mid-stage win for Alzheimer’s drug

Biogen and Eisai claim mid-stage win for Alzheimer’s drug

They estimate– based on Eisai’s earlier communications on the drug and trial design – that the clinical benefit could be around 20-25% and “certainly very clinically meaningful”if so.

Latest news

  • ICER says price of Amgen/Novartis’ Aimovig is OK - if used last-line ICER says price of Amgen/Novartis’ Aimovig is OK - if used last-line

    Novartis and Amgen’s decision to price their new migraine drug Aimovig lower than expected seems to have paid off, with US pricing watchdog ICER concluding that it matches the clinical ... ICER (the Institute for Clinical and Economic Review) estimates

  • Safety scuppers combo trials with J&J/Genmab’s Darzalex Safety scuppers combo trials with J&J/Genmab’s Darzalex

    There was a “numerical increase”in deaths when Darzalex was added to Tecentriq and no evidence of any increase in clinical benefit compared to Tecentriq on its own in the LUC2001 ... We are pleased that the development program for daratumumab remains

  • Daily Brief Daily Brief

    The company has a second drug, cancer candidate Clevegen, a novel anti-Clever-1 antibody, which enters clinical trials later this year. ... They say the algorithm takes into account the actual costs of R&D, manufacturing, sales, marketing and a fair

  • Another IO knockback as Tecentriq combo fails phase III trial Another IO knockback as Tecentriq combo fails phase III trial

    cancer (CRC) showed no benefit on overall survival compared to Bayer’s Stivarga (regorafenib), a drug typically used in that hard-to-treat population. ... The results from IMblaze370 were consistent with this prior monotherapy experience, showing that

  • New industry standards group launched New industry standards group launched

    New industry standards group launched. Align Clinical CRO will improve clinical trial collaboration. ... Henry Levy, president of Align Clinical CRO, said: “There’s tremendous potential to enhance clinical trial execution through common technology

More from news
Approximately 1 fully matching, plus 152 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.

Latest appointments

  • Dr Irina Antonijevic joins vasopharm Dr Irina Antonijevic joins vasopharm

    In this role, Dr Antonijevic will be responsible for advancing the clinical development of the cerebrovascular specialist's lead orphan drug candidate, VAS203. ... Not only will we benefit from her clinical capabilities in our ongoing pivotal study of

  • ICON's CEO named chair of ACRO ICON's CEO named chair of ACRO

    ICON's CEO named chair of ACRO. Trade body for clinical research organisation elects Ciaran Murray. ... I look forward to continuing the work that ACRO has done in promoting our industry as one that conducts safe, ethical and high-quality clinical

  • Industry veteran Louis Nisbet joins Sygnature board Industry veteran Louis Nisbet joins Sygnature board

    The UK-based clinical research organisation (CRO) will benefit from Dr Nisbet's extensive experience in the life sciences industry, which includes spells in research at Roche, Glaxo and SmithKline.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Why and how doctors should be involved in startups

    provide useful clinical insight that can benefit a startup.

  • Immunotherapy in oncology

    These three states align with the clinical observations of response, stable disease and progression of disease. ... However, the group recognised that delayed responses and prolonged stable disease were having a significant survival benefit, underscoring

  • What will the NHS’s Capped Expenditure Process (CEP) mean for pharma?

    Balancing doctors’ demands for drugs that demonstrate strong clinical benefit and patient safety against medicines management teams’ focus on cost savings will be critical in CEP areas. ... In such areas, bringing together multi-disciplinary networks

  • How will the NHS’s new medicines savings drive affect pharma?

    Engagement tactics must balance clinicians’ demand for products that show strong clinical benefit and patient safety against medicines management teams’ focus on the cost savings that can be generated by specific ... full benefit of expensive drugs,

  • The Heart of the Matter 7: Reality Dawns

    In tandem, as the limitations of the 'gold standard' randomised clinical trial (RCT) data are increasingly exposed, European initiatives such as the Innovative Medicines Initiative GetReal and ADAPT-SMART underline how ... The Centre has four areas of

More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics